SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Neurology (multiple sclerosis) Referral — Barbara Jordan

PatientBarbara Jordan
Date of birth1982-02-21
IdentifiersMRN HR-ML030-SYN; SSN (made up) 000-30-6852
Document date2026-03-02
AuthorEvangeline Moss, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Multiple sclerosis diagnosed elsewhere in a 44-year-old professor and public speaker who walks with a cane, with records of the original evaluation not available. Please confirm and classify the disease on the MRI booked for the morning of your visit, and advise on disease-modifying therapy, its screening and monitoring, vaccination, symptom care and MRI follow-up. [S]

Urgency: Within two weeks, on the same day as her two-week primary care visit. [S]

Questions for the consultant:

History of Present Illness

By her account multiple sclerosis was diagnosed elsewhere some years ago; she has no records and recalls no attack that came on over days and recovered. Her walking has worsened slowly over the past few years: she began using a cane while still in her previous public office, and now rests after about 100 meters. Leg stiffness, afternoon fatigue, heat sensitivity, urinary urgency and nocturia twice. Two near-falls and no falls in the past year. No previous disease-modifying therapy; she recalls steroid courses in the past. Today: blood pressure 124/78, weight 84.0 kg, BMI 28.1; spastic paraparetic gait with a cane; post-void residual 40 mL by bladder scan; PHQ-9 6. Results today: white cells 6.4, lymphocytes 1.9, hemoglobin 13.2 g/dL, platelets 262; creatinine 0.78 mg/dL, eGFR 96; ALT 18, AST 20, alkaline phosphatase 72 U/L, bilirubin 0.5 mg/dL; TSH 1.8; vitamin B12 520 pg/mL; 25-hydroxyvitamin D 17 ng/mL, so vitamin D3 started; IgG 1080, IgM 110, IgA 210 mg/dL; JC virus antibody index 0.14. Hepatitis B serology, varicella and measles immunity, tuberculosis blood test, HIV and hepatitis C are pending. MRI of the brain and cervical and thoracic spine with gadolinium is booked for the morning of your visit. She keeps her diagnosis private and decides who receives this letter [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Cholecalciferol (vitamin D3) 2000 units (50 mcg) oral capsule, one capsule dailyOne capsule dailyOral route2026-03-02activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Multiple sclerosis diagnosed elsewhere, by her account, with records of the original evaluation not available: slowly worsening walking over the past few years, leg stiffness, fatigue, urinary urgency and heat sensitivity; uses a cane; course to be classified after MRI of the brain and spineactiveconfirmed G35.DS — Synthetic presenting picture at intake, superseded by the classified diagnosis at the consultation; the cane and a diagnosis around the time she left Congress are from public accounts.
Spastic gait from multiple sclerosis, walking with a cane, with two near-falls and no falls in the past year; at risk of fallsactiveconfirmed R26.89S — Synthetic modern coding anchored to her documented cane.
Neurogenic bladder from multiple sclerosis: urgency and getting up twice at night, with a low post-void residualactiveconfirmed N31.9S — Synthetic; common in multiple sclerosis. No public source describes her bladder.
Vitamin D deficiencyactiveconfirmed E55.9S — Synthetic laboratory finding at intake.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1978Walking difficulty needing a cane in her last years in the House, attributed publicly at the time to a knee problemD (CLM-0005)
1979Multiple sclerosis diagnosed around the time she left Congress, as later revealed; records of that evaluation are not available to this clinicD (CLM-0006)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-03-02Body height173cmS
2026-03-02Body weight84kgS
2026-03-02Body mass index (BMI) [Ratio]28.1kg/m2S
2026-03-02Systolic blood pressure124mm[Hg]S
2026-03-02Diastolic blood pressure78mm[Hg]S
2026-03-02Heart rate76/minS
2026-03-02Respiratory rate16/minS
2026-03-02Body temperature36.7CelS
2026-03-02Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-02Leukocytes [#/volume] in Blood by Automated count6.410*3/uL4-11 10*3/uLNormalS
2026-03-02Lymphocytes [#/volume] in Blood by Automated count1.910*3/uL1-4.8 10*3/uLNormalS
2026-03-02Hemoglobin [Mass/volume] in Blood13.2g/dL12-15.5 g/dLNormalS
2026-03-02Platelets [#/volume] in Blood by Automated count26210*3/uL150-400 10*3/uLNormalS
2026-03-02Creatinine [Mass/volume] in Serum or Plasma0.78mg/dL0.59-1.04 mg/dLNormalS
2026-03-02Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M96mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-03-02Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma18U/L7-35 U/LNormalS
2026-03-02Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma20U/L10-35 U/LNormalS
2026-03-02Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma72U/L35-105 U/LNormalS
2026-03-02Bilirubin.total [Mass/volume] in Serum or Plasma0.5mg/dL0.2-1.2 mg/dLNormalS
2026-03-02Thyrotropin [Units/volume] in Serum or Plasma1.8m[IU]/L0.4-4.5 mIU/LNormalS
2026-03-02Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma520pg/mL232-1245 pg/mLNormalS
2026-03-0225-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma17ng/mL30-100 ng/mLLowS
2026-03-02IgG [Mass/volume] in Serum or Plasma1080mg/dL700-1600 mg/dLNormalS
2026-03-02IgM [Mass/volume] in Serum or Plasma110mg/dL40-230 mg/dLNormalS
2026-03-02IgA [Mass/volume] in Serum or Plasma210mg/dL70-400 mg/dLNormalS
2026-03-02JC virus Ab Index in Serum or Plasma by Immunoassay0.14{index}Below 0.20 negative; 0.20 to 0.40 indeterminate; above 0.40 positiveNormalS
2026-03-02Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S

Assessment

Plan of Treatment